Abstract
A new modular automated enzyme immunoassay (EIA) (Enzymun-Test HIV Ag: Boehringer Mannheim) for quantitative human immunodeficiency virus (HIV) antigen detection was evaluated by testing a panel of 1,506 serum samples, including seroconversions, dilution series, follow-up samples from patients under antiretroviral therapy, single serum specimens from HIV-seropositive individuals in different stages of infection, potentially cross-reactive samples, and sera from HIV-negative hospitalized patients. The Abbott HIV type 1 (HIV-1) antigen monoclonal antibody assay served as the reference assay, and nucleic acid sequence-based amplification (Organon Teknika) for quantitative amplification of HIV-1 RNA was used for follow-up of patients under antiretroviral chemotherapy. The Boehringer Mannheim and Abbott EIAs showed concordant results for the early detection of HIV antigen in all the seroconversion panels. The follow-up samples from 29 HIV-infected individuals under antiretroviral therapy gave divergent results between both antigen tests. For the detection of HIV antigen in single serum samples from HIV-infected patients in different stages of HIV infection, a higher number of positive samples was detected with the Abbott HIV-1 antigen monoclonal antibody assay in samples from patients in stages II and III of HIV infection. The Enzymun-Test detected three or more positive samples than did the Abbott assay among the samples of patients with AIDS. The concordance on a sample-to-sample basis between the Boehringer Mannheim and Abbott EIAs was 98.6%. The sensitivity of the Enzymun-Test in comparison to the reference assay was 97.2%; the specificity was 98.8%. Although no close correlation could be found between the amount of viral RNA in serum detected by nucleic acid sequence-based amplification and the concentration of HIV antigen, a high HIV-1 RNA copy number was mostly associated with high levels of HIV antigen. In conclusion, the Enzymun-Test permits accurate HIV antigen detection and offers, in contrast to previous assays, the possibility of completely automated detection.
Full Text
The Full Text of this article is available as a PDF (433.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baillou A., Barin F., Allain J. P., Petat E., Kocheleff P., Kadende P., Goudeau A. Human immunodeficiency virus antigenemia in patients with AIDS and AIDS-related disorders: a comparison between European and Central African populations. J Infect Dis. 1987 Nov;156(5):830–833. doi: 10.1093/infdis/156.5.830. [DOI] [PubMed] [Google Scholar]
- Borkowsky W., Krasinski K., Pollack H., Hoover W., Kaul A., Ilmet-Moore T. Early diagnosis of human immunodeficiency virus infection in children less than 6 months of age: comparison of polymerase chain reaction, culture, and plasma antigen capture techniques. J Infect Dis. 1992 Sep;166(3):616–619. doi: 10.1093/infdis/166.3.616. [DOI] [PubMed] [Google Scholar]
- Chaisson R. E., Leuther M. D., Allain J. P., Nusinoff-Lehrman S., Boone G. S., Feigal D., Volberding P. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial. Arch Intern Med. 1988 Oct;148(10):2151–2153. [PubMed] [Google Scholar]
- Garry R. F., Fermin C. D. Viral burden in AIDS. Nature. 1993 Sep 23;365(6444):301–302. doi: 10.1038/365301b0. [DOI] [PubMed] [Google Scholar]
- Gürtler L. G., Hauser P. H., Eberle J., von Brunn A., Knapp S., Zekeng L., Tsague J. M., Kaptue L. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol. 1994 Mar;68(3):1581–1585. doi: 10.1128/jvi.68.3.1581-1585.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hammer S., Crumpacker C., D'Aquila R., Jackson B., Lathey J., Livnat D., Reichelderfer P. Use of virologic assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee. J Clin Microbiol. 1993 Oct;31(10):2557–2564. doi: 10.1128/jcm.31.10.2557-2564.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Henrard D. R., Wu S., Phillips J., Wiesner D., Phair J. Detection of p24 antigen with and without immune complex dissociation for longitudinal monitoring of human immunodeficiency virus type 1 infection. J Clin Microbiol. 1995 Jan;33(1):72–75. doi: 10.1128/jcm.33.1.72-75.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Loussert-Ajaka I., Ly T. D., Chaix M. L., Ingrand D., Saragosti S., Couroucé A. M., Brun-Vézinet F., Simon F. HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet. 1994 Jun 4;343(8910):1393–1394. doi: 10.1016/s0140-6736(94)92524-0. [DOI] [PubMed] [Google Scholar]
- Pokriefka R. A., Manzor O., Markowitz N. P., Saravolatz L. D., Kvale P., Donovan R. M. Increased detection of human immunodeficiency virus antigenemia after dissociation of immune complexes at low pH. J Clin Microbiol. 1993 Jun;31(6):1656–1658. doi: 10.1128/jcm.31.6.1656-1658.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spector S. A., Kennedy C., McCutchan J. A., Bozzette S. A., Straube R. G., Connor J. D., Richman D. D. The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker. J Infect Dis. 1989 May;159(5):822–828. doi: 10.1093/infdis/159.5.822. [DOI] [PubMed] [Google Scholar]
- Tersmette M., Winkel I. N., Groenink M., Gruters R. A., Spence R. P., Saman E., Van Der Groen G., Miedema F., Huisman J. G. Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV p24gag. Virology. 1989 Jul;171(1):149–155. doi: 10.1016/0042-6822(89)90521-7. [DOI] [PubMed] [Google Scholar]
- Van Kerckhoven I., Vercauteren G., Piot P., van der Groen G. Comparative evaluation of 36 commercial assays for detecting antibodies to HIV. Bull World Health Organ. 1991;69(6):753–760. [PMC free article] [PubMed] [Google Scholar]
- Vanden Haesevelde M., Decourt J. L., De Leys R. J., Vanderborght B., van der Groen G., van Heuverswijn H., Saman E. Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J Virol. 1994 Mar;68(3):1586–1596. doi: 10.1128/jvi.68.3.1586-1596.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]